Tissue expression
Cell line expression
Protein structure

ABO

ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
A3GALNT, A3GALT1 
This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
843 antibodies from 24 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
NSJ Bioreagents
10 antibodies
Invitrogen Antibodies
44 antibodies
antibodies-online
454 antibodies
Novus Biologicals
192 antibodies
GeneTex
3 antibodies
OriGene
4 antibodies
Abnova Corporation
1 antibody
Signalway Antibody LLC
1 antibody
Biorbyt
4 antibodies
Creative Biolabs
21 antibodies
Aviva Systems Biology
3 antibodies
Abgent
3 antibodies
International Blood Group Reference Laboratory
8 antibodies
Bioworld Technology, Inc
1 antibody
Proteintech Group
1 antibody
Leading Biology
20 antibodies
Creative Diagnostics
4 antibodies
GenWay
5 antibodies
RabMAbs
1 antibody
United States Biological
10 antibodies
Abbexa
3 antibodies
MilliporeSigma / Merck KGaA
2 antibodies